Published in Cancer Weekly, October 24th, 2000
Conducted by Charles S. Cleeland, PhD, and associates at the M.D. Anderson Cancer Center in Houston, Texas, the study also indicated that the "core" items are sensitive to expected differences in symptoms and treatment side effects.
"Ratings of the relative severity of pain in cancer patients have been used as a basis for defining critical treatment pathways, for quality...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.